Search

Study titled "Safety and Immunogenicity of an Accelerated Schedule of the OspA Vaccine for Lyme Disease." The company, by then named Aventis Pasteur, Inc., informed Malawista on January 14, 2000, of its decision to stop work on the vaccine.

Notebook is about procedures such as "Harvesting White Cells." Most of the volume is blank.